Stocks
Intra-Cellular Therapies (ITCI) FCF/share US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| FCF/share, rub | -2.33 | -3.27 | -3.20 | -2.88 | -1.30 | -1.02 | |||
| Changes by years, y/y, % | +8% | +40% | -2% | -10% | -55% | -9.7% | |||
Intra-Cellular Therapies. FCF/share, rub
Intra-Cellular Therapies. FCF/share, changes, %
Intra-Cellular Therapies (ITCI) FCF/share US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| FCF/share, rub | -0.63 | -0.38 | -0.27 | -0.02 | -0.35 | -1.02 | ||
| Changes by years, y/y, % | -30% | -62% | -53% | -95% | -44% | |||
| Changes by quarters, q/q, % | +53% | -39% | -31% | -92% | +1 544% | |||
